Literature DB >> 21078840

Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles.

Gary J W Liao1, Fiona M F Lun, Yama W L Zheng, K C Allen Chan, Tak Y Leung, Tze K Lau, Rossa W K Chiu, Y M Dennis Lo.   

Abstract

BACKGROUND: Massively parallel sequencing has recently been used in noninvasive prenatal diagnosis. The current costs of this technology are still relatively expensive, however, and sample throughput is still relatively low when it is used as a molecular diagnostic tool. Rather than nonselectively sequencing the genome, target enrichment provides a logical approach for more efficient and cost-effective massively parallel sequencing because it increases the proportion of informative data from the targeted region(s). Existing applications of targeted sequencing have mainly been qualitative analyses of genomic DNA. In this study, we investigated its applicability in enriching selected genomic regions from plasma DNA and the quantitative performance of this approach.
METHODS: DNA was extracted from plasma samples collected from 12 pregnant women carrying female fetuses. The SureSelect Target Enrichment System (Agilent Technologies) was used to enrich for exons on chromosome X. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of the mother and fetus for each case were genotyped by microarray.
RESULTS: For the regions targeted by the enrichment kit, the mean sequence coverage of the enriched samples was 213-fold higher than that of the nonenriched samples. Maternal and fetal DNA molecules were enriched evenly. After target enrichment, the coverage of fetus-specific alleles within the targeted region increased from 3.5% to 95.9%.
CONCLUSIONS: Targeted sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles at genomic regions of interest and is a powerful method for measuring the proportion of fetal DNA in a maternal plasma sample.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078840     DOI: 10.1373/clinchem.2010.154336

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  40 in total

Review 1.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 2.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

3.  An SNP panel for the analysis of paternally inherited alleles in maternal plasma using ion Torrent PGM.

Authors:  Donggui Yang; Hao Liang; Shaobin Lin; Qing Li; Xiaoyan Ma; Jun Gao; Hongyu Sun; Qingqing Chen; Jianzhu Wu; Xueling Ou
Journal:  Int J Legal Med       Date:  2017-04-20       Impact factor: 2.686

4.  Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context.

Authors:  Megan Allyse; Lauren C Sayres; Jaime S King; Mary E Norton; Mildred K Cho
Journal:  Hum Reprod       Date:  2012-08-03       Impact factor: 6.918

5.  Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.

Authors:  Stephanie C Y Yu; K C Allen Chan; Yama W L Zheng; Peiyong Jiang; Gary J W Liao; Hao Sun; Ranjit Akolekar; Tak Y Leung; Attie T J I Go; John M G van Vugt; Ryoko Minekawa; Cees B M Oudejans; Kypros H Nicolaides; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 6.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

7.  Targeted capture enrichment and sequencing identifies extensive nucleotide variation in the turkey MHC-B.

Authors:  Kent M Reed; Kristelle M Mendoza; Robert E Settlage
Journal:  Immunogenetics       Date:  2016-01-05       Impact factor: 2.846

Review 8.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013

9.  SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy.

Authors:  Carole Samango-Sprouse; Milena Banjevic; Allison Ryan; Styrmir Sigurjonsson; Bernhard Zimmermann; Matthew Hill; Megan P Hall; Margaret Westemeyer; Jennifer Saucier; Zachary Demko; Matthew Rabinowitz
Journal:  Prenat Diagn       Date:  2013-06-20       Impact factor: 3.050

10.  Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci.

Authors:  Bernhard Zimmermann; Matthew Hill; George Gemelos; Zachary Demko; Milena Banjevic; Johan Baner; Allison Ryan; Styrmir Sigurjonsson; Nikhil Chopra; Michael Dodd; Brynn Levy; Matthew Rabinowitz
Journal:  Prenat Diagn       Date:  2012-10-30       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.